Vita Coco (NASDAQ: COCO) director receives 1,530 deferred RSUs and holds options

Rhea-AI Filing Summary

Vita Coco Company, Inc. director Jane Cecil Morreau received an equity grant of 1,530 shares of Common Stock on June 3, 2026, reported as deferred RSUs that will vest in full before the next annual stockholders meeting or on the first anniversary of the grant date, subject to continued board service. Following this grant, she directly holds 18,709 Common shares. She also holds a fully vested, currently exercisable non-qualified stock option covering 30,500 Common shares at an exercise price of $10.178 per share, expiring on July 12, 2031.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Morreau Jane Cecil

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	1,530	$75.18	$115K
holding	Non-Qualified Stock Option (Right to Buy)	--	--	--

Holdings After Transaction: Common Stock — 18,709 shares (Direct, null); Non-Qualified Stock Option (Right to Buy) — 30,500 shares (Direct, null)

Footnotes (1)

1. Represents deferred RSUs granted under the Issuers 2021 Incentive Award Plan which vest in full the earlier of (i) the day immediately preceding the Annual Stockholders Meeting after the grant date or (ii) the first anniversary of the grant date provided that the Reporting Person remains in continuous service on the applicable vesting date. The Reporting Persons deferred RSUs will settle on the date the Reporting Person ceases service on the Board. Each deferred RSU represents the right to receive one share of common stock of the Issuer. The stock option is fully vested and currently exercisable.

Key Figures

Deferred RSU grant: 1,530 shares Post-grant common holdings: 18,709 shares Option exercise price: $10.178/share +3 more

6 metrics

Deferred RSU grant 1,530 shares Equity award to director on June 3, 2026

Post-grant common holdings 18,709 shares Common Stock directly held after transaction

Option exercise price $10.178/share Non-qualified stock option on 30,500 underlying shares

Option underlying shares 30,500 shares Common Stock underlying fully vested option

Option expiration July 12, 2031 Expiration date of non-qualified stock option

RSU reference price $75.18/share Price per share shown for 1,530-share Common Stock grant

Key Terms

Non-Qualified Stock Option (Right to Buy), deferred RSUs, 2021 Incentive Award Plan, vesting, +1 more

5 terms

Non-Qualified Stock Option (Right to Buy) financial

"Non-Qualified Stock Option (Right to Buy) fully vested and currently exercisable"

deferred RSUs financial

"Represents deferred RSUs granted under the Issuers 2021 Incentive Award Plan"

2021 Incentive Award Plan financial

"deferred RSUs granted under the Issuers 2021 Incentive Award Plan which vest in full"

vesting financial

"which vest in full the earlier of the next Annual Stockholders Meeting or first anniversary"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

Common Stock financial

"Each deferred RSU represents the right to receive one share of common stock"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Morreau Jane Cecil

(Last) (First) (Middle)

111 5TH AVENUE

2ND FLOOR

(Street)

NEW YORK NEW YORK 10003

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Vita Coco Company, Inc. [ COCO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/03/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/03/2026		A		1,530(1)	A	$75.18	18,709	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Non-Qualified Stock Option (Right to Buy)	$10.178							(2)	07/12/2031	Common Stock	30,500		30,500	D

Explanation of Responses:

1. Represents deferred RSUs granted under the Issuers 2021 Incentive Award Plan which vest in full the earlier of (i) the day immediately preceding the Annual Stockholders Meeting after the grant date or (ii) the first anniversary of the grant date provided that the Reporting Person remains in continuous service on the applicable vesting date. The Reporting Persons deferred RSUs will settle on the date the Reporting Person ceases service on the Board. Each deferred RSU represents the right to receive one share of common stock of the Issuer.

2. The stock option is fully vested and currently exercisable.

	Alison Klein, Attorney-in-Fact for Jane Morreau	06/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Vita Coco (COCO) disclose for Jane Cecil Morreau?

Vita Coco reported that director Jane Cecil Morreau received an equity grant of 1,530 Common shares on June 3, 2026. These are deferred RSUs that vest based on her continued board service and will settle when she leaves the board.

How many Vita Coco (COCO) shares does Jane Cecil Morreau hold after this Form 4?

After the reported grant, Jane Cecil Morreau directly holds 18,709 shares of Vita Coco Common Stock. This reflects her updated direct ownership following the 1,530-share deferred RSU award disclosed in the Form 4 filing.

What are the terms of Jane Cecil Morreau’s stock options at Vita Coco (COCO)?

Jane Cecil Morreau holds a fully vested non-qualified stock option to acquire 30,500 Vita Coco Common shares at an exercise price of $10.178 per share. The option is currently exercisable and is scheduled to expire on July 12, 2031.

How do the deferred RSUs granted to Jane Cecil Morreau at Vita Coco (COCO) vest?

The deferred RSUs vest in full on the earlier of the day immediately before the next annual stockholders meeting after grant or the first anniversary of the grant date. Vesting requires that Jane Cecil Morreau remain in continuous board service until that date.

When will Jane Cecil Morreau’s deferred RSUs in Vita Coco (COCO) settle into shares?

The deferred RSUs will settle into Vita Coco Common shares on the date Jane Cecil Morreau ceases service on the board. Each deferred RSU represents the right to receive one share of Vita Coco Common Stock at settlement.